New drug combo takes on Hard-to-Treat prostate cancer
NCT ID NCT06863272
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 4 times
Summary
This study tests a new drug called ifinatamab deruxtecan (I-DXd), given alone or with other treatments, in men with metastatic castration-resistant prostate cancer (mCRPC) that has worsened despite hormone therapy. The trial aims to find safe doses and see if the drug can lower PSA levels and shrink tumors. About 360 participants will take part across multiple sites.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ifinatamab deruxtecan (I-DXd), docetaxel, MK-5684, abiraterone, enzalutamide
- What this could lead to
- If it works, this could point toward a new treatment option for men with advanced prostate cancer that has stopped responding to hormone therapy.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with a small number of participants, so the drug may not prove effective or safe enough for wider use. Side effects could be serious, including severe toxicities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION RESISTANT PROSTATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
A.O.U. Federico II di Napoli ( Site 0435)
RECRUITINGNaples, 80131, Italy
-
AOU San Luigi Gonzaga di Orbassano ( Site 0434)
RECRUITINGOrbassano, Torino, 10143, Italy
-
Addenbrooke's Hospital ( Site 0747)
RECRUITINGCambridge, Cambridgeshire, CB2 2QQ, United Kingdom
-
Ankara Bilkent Şehir Hastanesi ( Site 0654)
RECRUITINGAnkara, 06800, Turkey (Türkiye)
-
Ankara Universitesi Tip Fakultesi Hastanesi ( Site 0653)
RECRUITINGAnkara, 06620, Turkey (Türkiye)
-
Asan Medical Center ( Site 0925)
RECRUITINGSongpagu, Seoul, 05505, South Korea
-
Auckland City Hospital ( Site 0831)
RECRUITINGAuckland, 1023, New Zealand
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( Site 0432)
RECRUITINGBrescia, 25123, Italy
-
BC Cancer - Vancouver Center ( Site 0103)
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
-
Baskent University Dr. Turgut Noyan Research and Training Center ( Site 0650)
RECRUITINGAdana, 01250, Turkey (Türkiye)
-
Beaumont Hospital, Dublin ( Site 0465)
RECRUITINGDublin, D09 V2N0, Ireland
-
Bradfordhill ( Site 0231)
RECRUITINGSantiago, Region M. de Santiago, 8420383, Chile
-
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0107)
RECRUITINGSherbrooke, Quebec, J1H 5N4, Canada
-
Centre Hospitalier de la Cote Basque ( Site 0496)
RECRUITINGBayonne, Pyrenees-Atlantiques, 64100, France
-
Centre Oscar Lambret ( Site 0495)
RECRUITINGLille, Nord, 59000, France
-
Centro de Oncología de Precisión ( Site 0241)
RECRUITINGSantiago, Region M. de Santiago, 7560908, Chile
-
Clinica Universidad Catolica del Maule ( Site 0236)
RECRUITINGTalca, Maule Region, 3465584, Chile
-
FALP ( Site 0232)
RECRUITINGSantiago, Region M. de Santiago, 7500921, Chile
-
Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0431)
RECRUITINGMilan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli ( Site 0433)
RECRUITINGRoma, 00168, Italy
-
Fred Hutchinson Cancer Center ( Site 0013)
RECRUITINGSeattle, Washington, 98109, United States
-
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200)
RECRUITINGLa Rioja, F5300COE, Argentina
-
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0263)
RECRUITINGSão José do Rio Preto, São Paulo, 15090-000, Brazil
-
Hacettepe Universitesi Tip Fakultesi ( Site 0648)
RECRUITINGAnkara, 06230, Turkey (Türkiye)
-
Hadassah Medical Center ( Site 0404)
RECRUITINGJerusalem, 9112001, Israel
-
Hospital Alemao Oswaldo Cruz ( Site 0279)
RECRUITINGSão Paulo, São Paulo, 01327-001, Brazil
-
Hospital Clinico San Carlos ( Site 0618)
RECRUITINGMadrid, 28040, Spain
-
Hospital Moinhos de Vento ( Site 0278)
RECRUITINGPorto Alegre, Rio Grande do Sul, 90035-001, Brazil
-
Hospital Universitario 12 de Octubre ( Site 0622)
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Ramon y Cajal ( Site 0620)
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Virgen del Rocio ( Site 0619)
RECRUITINGSeville, 41013, Spain
-
Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0268)
RECRUITINGBragança Paulista, São Paulo, 12916-542, Brazil
-
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) ( Site 0273)
RECRUITINGRibeirão Preto, São Paulo, 14048900, Brazil
-
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0269)
RECRUITINGSão Paulo, 03102-006, Brazil
-
ICO L Hospitalet ( Site 0617)
RECRUITINGL Hospitalet Del Llobregat, Barcelona, 08908, Spain
-
IPITEC ( Site 0275)
RECRUITINGSão Paulo, 01221-020, Brazil
-
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0498)
RECRUITINGBordeaux, Gironde, 33000, France
-
Institut De Cancerologie De L Ouest ( Site 0494)
RECRUITINGSaint-Herblain, Pays de la Loire Region, 44800, France
-
Instituto Alexander Fleming ( Site 0202)
RECRUITINGCiudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina
-
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0270)
RECRUITINGPorto Alegre, Rio Grande do Sul, 90020-090, Brazil
-
Istanbul Universitesi Cerrahpasa ( Site 0649)
RECRUITINGIstanbul, 34098, Turkey (Türkiye)
-
Koç Üniversitesi Hastanesi ( Site 0656)
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
Liga Norte Riograndense Contra o Câncer ( Site 0271)
RECRUITINGNatal, Rio Grande do Norte, 59062-000, Brazil
-
Macquarie University-MQ Health Clinical Trials Unit ( Site 0801)
RECRUITINGMacquarie University, New South Wales, 2109, Australia
-
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026)
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Memorial Sloan Kettering Cancer Center ( Site 0006)
RECRUITINGNew York, New York, 10065, United States
-
NCT ( Site 0528)
RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0586)
RECRUITINGWarsaw, Masovian Voivodeship, 02-781, Poland
-
Nij Smellinghe ( Site 0684)
RECRUITINGDrachten, Provincie Friesland, 9202 NN, Netherlands
-
ONCOCENTRO APYS ( Site 0234)
RECRUITINGViña del Mar, Valparaiso, 2520598, Chile
-
Princess Margaret Cancer Centre ( Site 0102)
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Rabin Medical Center ( Site 0402)
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Health Care Campus ( Site 0400)
RECRUITINGHaifa, 3109601, Israel
-
Recep Tayyip Erdogan University Training and Research Hospital ( Site 0655)
RECRUITINGRize, 53020, Turkey (Türkiye)
-
Royal Free Hospital ( Site 0743)
RECRUITINGLondon, London, City of, NW3 2QG, United Kingdom
-
Royal Marsden Hospital (Sutton) ( Site 0741)
RECRUITINGLondon, Surrey, SM3 5PT, United Kingdom
-
Samsung Medical Center ( Site 0926)
RECRUITINGSeoul, 06351, South Korea
-
Severance Hospital Yonsei University Health System ( Site 0924)
ACTIVE_NOT_RECRUITINGSeoul, 03722, South Korea
-
Sheba Medical Center ( Site 0401)
RECRUITINGRamat Gan, 5265601, Israel
-
Sourasky Medical Center ( Site 0403)
RECRUITINGTel Aviv, 6423906, Israel
-
St Bartholomew's Hospital ( Site 0749)
RECRUITINGLondon, London, City of, EC1A 7BE, United Kingdom
-
St Vincent's University Hospital ( Site 0463)
RECRUITINGDublin, Dublin, D04 T6F4, Ireland
-
Sunnybrook Research Institute ( Site 0109)
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Szpital Wojewódzki im. M.Kopernika Oddział Onk. Klinicznej z Pododdziałem Chemioterapii Jednodniowej ( Site 0587)
RECRUITINGKoszalin, West Pomeranian Voivodeship, 75-581, Poland
-
Taichung Veterans General Hospital ( Site 0902)
RECRUITINGTaichung, 40705, Taiwan
-
Taipei Veterans General Hospital ( Site 0901)
RECRUITINGTaipei, 11217, Taiwan
-
Tallaght University Hospital ( Site 0462)
RECRUITINGDublin, D24 NR0A, Ireland
-
The West Clinic, PLLC dba West Cancer Center ( Site 0005)
RECRUITINGGermantown, Tennessee, 38138, United States
-
UCLA Hematology & Oncology ( Site 0003)
RECRUITINGLos Angeles, California, 90095, United States
-
UCSF Medical Center at Mission Bay ( Site 0034)
RECRUITINGSan Francisco, California, 94158, United States
-
UMC St. Radboud ( Site 0679)
RECRUITINGNijmegen, Gelderland, 6525 GA, Netherlands
-
UPMC Hillman Cancer Center ( Site 0014)
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Universitaetsklinikum Hamburg-Eppendorf ( Site 0524)
RECRUITINGHamburg, 20246, Germany
-
Universitaetsklinikum Jena ( Site 0525)
RECRUITINGJena, Thuringia, 07747, Germany
-
Universitaetsklinikum Ulm. ( Site 0530)
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
-
University of California-Irvine Medical Center ( Site 0016)
RECRUITINGOrange, California, 92868, United States
-
University of Michigan ( Site 0021)
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 0590)
RECRUITINGPoznan, Greater Poland Voivodeship, 60-355, Poland
-
Uniwersyteckie Centrum Kliniczne ( Site 0588)
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
-
Ziekenhuis Gelderse Vallei ( Site 0683)
RECRUITINGEde, Gelderland, 6716 RP, Netherlands
-
centre hospitalier lyon sud ( Site 0497)
RECRUITINGPierre-Bénite, Rhone, 69310, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Can a new pill outsmart resistant prostate cancer?
- Can a radioactive 'Smart Bomb' outsmart advanced prostate cancer?
- Can an immune booster make hormone therapy work better against prostate cancer?
- Can a pill outsmart Tumors' defenses?
- Can targeted radiation tame advanced prostate cancer? a registry aims to find out